1. Home
  2. APP vs BSX Comparison

APP vs BSX Comparison

Compare APP & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Applovin Corporation

APP

Applovin Corporation

HOLD

Current Price

$458.69

Market Cap

141.6B

Sector

Technology

ML Signal

HOLD

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

HOLD

Current Price

$69.14

Market Cap

137.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APP
BSX
Founded
2012
1979
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
141.6B
137.8B
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
APP
BSX
Price
$458.69
$69.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
17
20
Target Price
$703.71
$108.75
AVG Volume (30 Days)
5.4M
11.3M
Earning Date
05-12-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
115.23
55.20
EPS
9.75
1.94
Revenue
$5,480,717,000.00
$9,076,000,000.00
Revenue This Year
$47.55
$12.04
Revenue Next Year
$29.08
$10.48
P/E Ratio
$46.10
$35.33
Revenue Growth
16.38
12.49
52 Week Low
$200.50
$67.56
52 Week High
$745.61
$109.50

Technical Indicators

Market Signals
Indicator
APP
BSX
Relative Strength Index (RSI) 47.99 30.45
Support Level $345.95 N/A
Resistance Level $473.69 $76.77
Average True Range (ATR) 25.69 1.87
MACD 7.04 0.06
Stochastic Oscillator 56.98 17.55

Price Performance

Historical Comparison
APP
BSX

About APP Applovin Corporation

AppLovin is a vertically integrated advertising technology company that acts as a demand-side platform for advertisers, a supply-side platform for publishers, and an exchange facilitating transactions between the two. About 80% of AppLovin's revenue comes from the DSP, AppDiscovery, while the remainder comes from the SSP, Max. AppLovin's primary tool for future growth is AXON 2, which is an ad optimizer operating within the DSP that allows advertisers to place ads according to specified return thresholds.

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Share on Social Networks: